Identification | Back Directory | [Name]
8,11,14-Eicosatrienoic acid, sodium salt, (Z,Z,Z)- (9CI) | [CAS]
65881-87-0 | [Synonyms]
8,11,14-Eicosatrienoic acid, sodium salt, (Z,Z,Z)- (9CI) | [Molecular Formula]
C20H35NaO2 | [MOL File]
65881-87-0.mol | [Molecular Weight]
330.49 |
Hazard Information | Back Directory | [Uses]
Dihomo-γ-linolenic acid (DGLA; all-cis-8,11,14-Eicosatrienoic acid) sodium is a 20-carbon ω-6 fatty acid, with anti-inflammatory and anti-proliferative activities. Dihomo-γ-linolenic acid (sodium) attenuates atherosclerosis in the apolipoprotein E deficient mouse model system[1][2][3]. | [References]
[1] Wang X, et al. Multiple roles of dihomo-γ-linolenic acid against proliferation diseases. Lipids Health Dis. 2012 Feb 14;11:25. DOI:10.1186/1476-511X-11-25 [2] Gallagher H, et al. Dihomo-γ-linolenic acid inhibits several key cellular processes associated with atherosclerosis. Biochim Biophys Acta Mol Basis Dis. 2019 Sep 1;1865(9):2538-2550. DOI:10.1016/j.bbadis.2019.06.011 [3] Gallagher H, et al. Dihomo-γ-linolenic acid inhibits several key cellular processes associated with atherosclerosis. Biochim Biophys Acta Mol Basis Dis. 2019 Sep 1;1865(9):2538-2550. DOI:10.1016/j.redox.2018.10.001 |
|
Company Name: |
Enzo Biochem Inc
|
Tel: |
Enzo Biochem Inc. 13797054060 |
Website: |
www.enzo.com |
|